These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26199129)

  • 1. Variation analysis of E1 and E2 in HCV subtypes.
    Cheng XD; Xu HF; Wei XM; Zhou HZ
    Arch Virol; 2015 Oct; 160(10):2479-82. PubMed ID: 26199129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralization.
    Anjum S; Wahid A; Afzal MS; Albecka A; Alsaleh K; Ahmad T; Baumert TF; Wychowski C; Qadri I; Penin F; Dubuisson J
    J Infect Dis; 2013 Dec; 208(11):1888-97. PubMed ID: 23908491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolutionary study of hepatitis C virus envelope genes during primary infection.
    Chen S; Wang YM
    Chin Med J (Engl); 2007 Dec; 120(24):2174-80. PubMed ID: 18167197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolutionary dynamics of the E1-E2 viral populations during combination therapy in non-responder patients chronically infected with hepatitis C virus subtype 1b.
    Saludes V; González-Candelas F; Planas R; Solà R; Ausina V; Martró E
    Infect Genet Evol; 2013 Jan; 13():1-10. PubMed ID: 23022712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insight into HCV E1/E2 region of genotype 4a.
    Hussein N; Zekri AR; Abouelhoda M; Alam El-Din HM; Ghamry AA; Amer MA; Sherif GM; Bahnassy AA
    Virol J; 2014 Dec; 11():231. PubMed ID: 25547228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment.
    Bolcic F; Sede M; Moretti F; Westergaard G; Vazquez M; Laufer N; Quarleri J
    Arch Virol; 2012 Apr; 157(4):703-11. PubMed ID: 22270759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization.
    Prentoe J; Jensen TB; Meuleman P; Serre SB; Scheel TK; Leroux-Roels G; Gottwein JM; Bukh J
    J Virol; 2011 Mar; 85(5):2224-34. PubMed ID: 21123377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.
    Douam F; Dao Thi VL; Maurin G; Fresquet J; Mompelat D; Zeisel MB; Baumert TF; Cosset FL; Lavillette D
    Hepatology; 2014 Mar; 59(3):776-88. PubMed ID: 24038151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).
    Hadlock KG; Gish R; Rowe J; Rajyaguru SS; Newsom M; Warford A; Foung SK
    J Med Virol; 2001 Sep; 65(1):23-9. PubMed ID: 11505439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus envelope glycoproteins complementation patterns and the role of the ecto- and transmembrane domains.
    Lin X; Zhang Y; Bi S; Lu J; Zhao H; Tan W; Li D; Wang Y
    Biochem Biophys Res Commun; 2009 Jul; 385(2):257-62. PubMed ID: 19464265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic variation characteristics of the envelope region of hepatitis C virus in the patients with chronic hepatitis].
    Chen S; Wang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):219-22. PubMed ID: 12665923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins.
    Shaw ML; McLauchlan J; Mills PR; Patel AH; McCruden EA
    J Med Virol; 2003 Jul; 70(3):361-72. PubMed ID: 12766998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.
    Nevot M; Boesecke C; Parera M; Andrés C; Franco S; Revollo B; Ingiliz P; Tural C; Clotet B; Rockstroh JK; Martinez MA;
    J Viral Hepat; 2014 Jun; 21(6):e19-28. PubMed ID: 24674023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quasispecies sequence analyses of envelope protein E1/E2 coding genes from four Chinese HCV patients and identification of a novel insertion mutation of HCV].
    Li CL; Zhang L; Lu J; Liu XM; Deng Y; Wang Y; Shen XL; Tan WJ
    Bing Du Xue Bao; 2012 Jun; 28(4):336-44. PubMed ID: 22978156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of amino acid variations in the NS3, NS4A and NS4B of HCV genotypes 1a, 1b, 3a, 3b and 6f on the response to pegylated interferon and ribavirin combination therapy.
    Chusri P; Kumthip K; Pantip C; Thongsawat S; O'Brien A; Maneekarn N
    Virus Res; 2015 Jan; 196():37-43. PubMed ID: 25445343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prevalence of hepatitis C virus (HCV) subtypes in Chinese HIV-1/HCV co-infected individuals].
    Liu J; Yang Y; Gong JL; Zhang ZN; Zhang M; Wang YN; Jiang YJ; Qi ZT; Pan QC; Zhong P; Shang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jul; 30(7):663-7. PubMed ID: 19957585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection.
    Humphreys I; Fleming V; Fabris P; Parker J; Schulenberg B; Brown A; Demetriou C; Gaudieri S; Pfafferott K; Lucas M; Collier J; Huang KH; Pybus OG; Klenerman P; Barnes E
    J Virol; 2009 Nov; 83(22):11456-66. PubMed ID: 19740991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.
    Gottwein JM; Scheel TK; Jensen TB; Lademann JB; Prentoe JC; Knudsen ML; Hoegh AM; Bukh J
    Hepatology; 2009 Feb; 49(2):364-77. PubMed ID: 19148942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different levels of variability in subtypes 1b and 4a of hepatitis C viruses.
    Argentini C; Dettori S; Villano U; Angelico M; Rapicetta M
    J Biol Regul Homeost Agents; 2003; 17(2):147-52. PubMed ID: 14518714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis.
    Genovese D; Dettori S; Argentini C; Villano U; Chionne P; Angelico M; Rapicetta M
    J Clin Microbiol; 2005 Apr; 43(4):1902-9. PubMed ID: 15815016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.